ENTRY       D00432                      Drug
NAME        Nadolol (JP18/USP/INN);
            Corgard (TN)
PRODUCT     CORGARD (USWM)
  GENERIC   NADOLOL (Alembic Pharmaceuticals Limited)
            NADOLOL (Alembic Pharmaceuticals)
            NADOLOL (American Health Packaging)
            NADOLOL (Amneal Pharmaceuticals NY LLC)
            NADOLOL (Aurobindo Pharma Limited)
            NADOLOL (Bayshore Pharmaceuticals LLC)
            NADOLOL (BluePoint Laboratories)
            NADOLOL (Bryant Ranch Prepack)
            NADOLOL (Bryant Ranch Prepack)
            NADOLOL (Bryant Ranch Prepack)
            NADOLOL (Cipla USA)
            NADOLOL (Exelan Pharmaceuticals)
            NADOLOL (Greenstone LLC)
            NADOLOL (InvaGen Pharmaceuticals)
            NADOLOL (Major Pharmaceuticals)
            NADOLOL (Marlex Pharmaceuticals)
            NADOLOL (Mylan Pharmaceuticals)
            NADOLOL (REMEDYREPACK)
            NADOLOL (REMEDYREPACK)
            NADOLOL (Sandoz)
            NADOLOL (VGYAAN Pharmaceuticals LLC)
            NADOLOL (Zydus Lifesciences Limited)
            NADOLOL (Zydus Pharmaceuticals USA)
FORMULA     C17H27NO4
EXACT_MASS  309.194
MOL_WEIGHT  309.4006
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01464  beta-Adrenergic receptor antagonist (Beta blocker)
             DG01653  Antiarrhythmics
              DG01806  Class II antiarrhythmic agent
             DG03231  Antihypertensive
REMARK      Therapeutic category: 2123 2149
            ATC code: C07AA12
            Product: D00432<JP/US>
EFFICACY    Antiarrhythmic, Antihypertensive, Vasodilator, beta-Adrenergic receptor antagonist
  DISEASE   Angina Pectoris [DS:H01632]
            Hypertension [DS:H01633]
COMMENT     Propranolol derivative
TARGET      ADRB1 [HSA:153] [KO:K04141]
            ADRB2 [HSA:154] [KO:K04142]
  PATHWAY   hsa04020(153+154)  Calcium signaling pathway
            hsa04022(153+154)  cGMP-PKG signaling pathway
            hsa04024(153+154)  cAMP signaling pathway
            hsa04080(153+154)  Neuroactive ligand-receptor interaction
            hsa04261(153+154)  Adrenergic signaling in cardiomyocytes
INTERACTION  
STR_MAP     map07048  Antimigraines
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C07 BETA BLOCKING AGENTS
               C07A BETA BLOCKING AGENTS
                C07AA Beta blocking agents, non-selective
                 C07AA12 Nadolol
                  D00432  Nadolol (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Beta-adrenergic Blocking Agents
               Non-Selective
                Nadolol
                 D00432  Nadolol (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               212  Antiarrhythmic agents
                2123  Beta blockers
                 D00432  Nadolol (JP18/USP/INN)
               214  Antihypertensives
                2149  Others
                 D00432  Nadolol (JP18/USP/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01464  beta-Adrenergic receptor antagonist (Beta blocker)
                D00432  Nadolol
              DG01653  Antiarrhythmics
               DG01806  Class II antiarrhythmic agent
                D00432  Nadolol
              DG03231  Antihypertensive
               D00432  Nadolol
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG03231  Antihypertensive
               D00432  Nadolol
              DG01653  Antiarrhythmics
               D00432  Nadolol
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRB1
                 D00432  Nadolol (JP18/USP/INN) &lt;JP/US&gt;
                ADRB2
                 D00432  Nadolol (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00432  Nadolol
DBLINKS     CAS: 42200-33-9
            PubChem: 7847498
            ChEBI: 7444
            LigandBox: D00432
            NIKKAJI: J16.444E
ATOM        22
            1   O2a O    25.1300  -25.3400
            2   C1b C    26.3200  -24.6400
            3   C1c C    27.5800  -25.3400
            4   C1b C    28.7700  -24.6400
            5   O1a O    27.5800  -26.8100
            6   N1b N    29.9600  -25.3400
            7   C1d C    31.2200  -24.6400
            8   C1a C    32.4800  -25.3400
            9   C1a C    31.2200  -23.4500
            10  C1a C    32.4800  -23.9400
            11  C8y C    25.1300  -26.7400
            12  C8y C    23.9400  -27.4400
            13  C8y C    23.9400  -28.8400
            14  C8x C    25.1300  -29.5400
            15  C8x C    26.3200  -28.8400
            16  C8x C    26.3200  -27.4400
            17  C1x C    22.7276  -26.7400
            18  C1y C    21.5151  -27.4400
            19  C1y C    21.5151  -28.8400
            20  C1x C    22.7276  -29.5400
            21  O1a O    20.2840  -26.7290
            22  O1a O    20.2840  -29.5510
BOND        23
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     3   5 1
            5     4   6 1
            6     6   7 1
            7     7   8 1
            8     7   9 1
            9     7  10 1
            10    1  11 1
            11   11  12 2
            12   12  13 1
            13   13  14 2
            14   14  15 1
            15   15  16 2
            16   11  16 1
            17   12  17 1
            18   17  18 1
            19   18  19 1
            20   19  20 1
            21   13  20 1
            22   18  21 1 #Up
            23   19  22 1 #Up
///
